SCHEMBL3848717

SCHEMBL3848717

FC(F)(F)c1cccc(N2CCN(c3ccnc4ccc(-c5cnn(C(c6ccccc6)(c6ccccc6)c6ccccc6)c5)cc34)CC2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 2/20 0.45
DHFR P00374 1/20 0.43
DRD2 P14416 4/20 0.42
DRD3 P35462 4/20 0.42
ADRA1A P35348 2/20 0.42
MAPT P10636 2/20 0.42
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
GRM4 Q14833 1/20 0.41
RPS6KB1 P23443 1/20 0.41
AKT1 P31749 1/20 0.41
SMO Q99835 1/20 0.40
PHGDH O43175 4/20 0.40
TP53 P04637 1/20 0.39
DRD5 P21918 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
ADRB2 P07550 1/20 0.39
NCF1 P14598 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845844 0.86 PHGDH (0.47) MAPKAPK2DRD2DRD3ADRA1AMAPT
SCHEMBL3846521 0.85 MAPKAPK2 (0.46) MAPKAPK2ALDH1A1
SCHEMBL3850389 0.84 MAPKAPK2 (0.39) MAPKAPK2DHFRDRD2DRD3ADRA1A
SCHEMBL3848119 0.83 MAPKAPK2 (0.44) MAPKAPK2DHFRDRD2DRD3ADRA1A
SCHEMBL3851514 0.79 CHRM4 (0.42) NCF1
Hydrochloric Acid SCHEMBL3847773 0.79 MAPKAPK2 (0.47) MAPKAPK2DHFRDRD2DRD3ADRA1A
SCHEMBL3846401 0.77 ALK (0.36) MAPKAPK2GRM4NCF1
SCHEMBL3846556 0.77 NCF1 (0.56) MAPKAPK2DHFRDRD2DRD3MAPT
SCHEMBL3845891 0.76 ACHE (0.47) MAPTALDH1A1TSHRSMN1; SMN2TP53
SCHEMBL5852369 0.76 CYP1A2 (0.43) MAPTALDH1A1TSHRSMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed